$13.48
-0.09-0.66%
最終更新: Oct 1, 6:39 PM
$13.63
0.060.44%
Benzinga
Benzinga
Benzinga
金曜日, 10 02
Benzinga
© 2026 Benzinga | All Rights Reserved
Chemours (CC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Chemours (CC) は、8 4, 2026日にfiscal yearの2026に関するガイダンスを直近で発表しました。同社は当期の売上高を$5.87B - $6.1Bの範囲と予想しています。
以前のガイダンスと比較して、Chemoursは売上高予測を以前の範囲である維持から$5.98B - $6.1Bに引き上げました。
Chemoursは、15から4 28, 2023の間に8 4, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 3 times and lowered it 8 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.42 | $-0.04 | $0.02 | $0.24 |
| Actual | $0.42 | $0.05 | $0.05 | $0.20 |
| Surprise | 0.00% | +225.0% | +150.0% | -16.7% |
| Revenue | ||||
| Estimate | $1.66B | $1.40B | $1.33B | $1.49B |
| Actual | $1.59B | $1.38B | $1.30B | $1.50B |
| Surprise | -4.13% | -1.30% | -2.18% | +0.01% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.27 | $0.22 | $0.38 | $0.66 |
| Revenue | ||||
| Consensus | $1.54B | $1.42B | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $0.42 | $0.42 | 0.00 % |
| Q1 | May 5, 2026 | $0.05 | $-0.04 | 225.0 % |
| Q4 | Feb 19, 2026 | $0.05 | $0.02 | 150.0 % |
| Q3 | Nov 6, 2025 | $0.20 | $0.24 | -16.7 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $1.59B | $1.66B | -4.13 % |
| Q1 | May 5, 2026 | $1.38B | $1.40B | -1.30 % |
| Q4 | Feb 19, 2026 | $1.30B | $1.33B | -2.18 % |
| Q3 | Nov 6, 2025 | $1.50B | $1.49B | 0.01 % |